Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications?
HIV Medicine · 2025-08 · 26 (8) · 1317-1320
DOI: 10.1111/hiv.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 16.06.2025. Verfasst von Arda Kaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Ege University Faculty of Medicine, İzmir, Turkey. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Ege University Faculty of Medicine, İzmir, Turkey.
- Department of Medicine I, University Hospital Bonn, Bonn, Germany.
- GlobalHealth Consultant, Barcelona, Spain.
ORCID-Profile: Arda Kaya, Dominik Benke, Sven Breitschwerdt, Christoph Boesecke, Jürgen Kurt Rockstroh
Zitieren
APA
Kaya, A., Benke, D., Swan, T., Breitschwerdt, S., Wasmuth, J. C., Boesecke, C., & Rockstroh, J. K. (2025). Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications?. HIV Medicine, 26(8), 1317-1320. https://doi.org/10.1111/hiv.70063
Vancouver
Kaya A, Benke D, Swan T, Breitschwerdt S, Wasmuth JC, Boesecke C, et al. Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications?. HIV Medicine. 2025;26(8):1317-1320. doi:10.1111/hiv.70063
BibTeX
@article{Kaya2025,
author = {Kaya, Arda and Benke, Dominik and Swan, Tracy and Breitschwerdt, Sven and Wasmuth, Jan-Christian and Boesecke, Christoph and Rockstroh, Jürgen Kurt},
title = {Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications?},
journal = {HIV Medicine},
year = {2025},
volume = {26},
number = {8},
pages = {1317--1320},
doi = {10.1111/hiv.70063}
}
EUVIMED